Personnel Information

写真a

ARAI Ayako


Job title

Professor

Research Areas, Keywords

hematopoistic neoplasms, lymphoma, Epstein-Barr virus, lymphoma, chronic active EBV infection
To the head of this page.▲

Graduating School 【 display / non-display 】

  • Niigata University, Faculty of Medicine, 1988.03, Graduated

To the head of this page.▲

Graduate School 【 display / non-display 】

  • Tokyo Medical and Dental University, Graduate School, Division of Medical Sciences, Doctor's Course, 2000.03, Completed

To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2008.04
    -
    2017.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences， Hematology， Junior Associate Professor
  • 2006.08
    -
    2018.03
    Tokyo Medical and Dental University， Medical Hospital， Hospital Departments， Department of Internal Medicine， Hematology， Assistant Professor
  • 2005.04
    -
    2006.07
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences， Hematology， Assistant Professor
  • 2017.04
    -
    2018.03
    Tokyo Medical and Dental University， Graduate School of Health Care Sciences， Biomedical Laboratory Sciences， Moleculo-genetic Sciences， Laboratory Molecular Genetics of Hematology， Associate Professor
  • 2018.04
    -
    2019.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， -， -， Department of Laboratory Molecular Genetics of Hematology， Associate Professor

display all >>

To the head of this page.▲

Academic Society Affiliations 【 display / non-display 】

  • The Japanese Society of Internal Medicine

  • The Japanese Society of Hematology

  • The Japan Society for Hematopoietic Cell Transplantation

  • Japanese Cancer Association

  • Japanese Society of Clinica1 Oncology

display all >>

To the head of this page.▲

Research Areas 【 display / non-display 】

  • Hematology

To the head of this page.▲

Qualification Acquired 【 display / non-display 】

  • Doctor

To the head of this page.▲
 

Research Theme 【 display / non-display 】

  • EBV-induced T- of NK-cell neoplasms; molecular mechanisms of the development and establishment of the new treatment strategy

To the head of this page.▲

Published Papers & Misc 【 display / non-display 】

  • Hiroyuki Takahashi, Hiroshi Takase, Ayako Arai, Manabu Mochizuki, Kyoko Ohno-Matsui. Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein-Barr virus infection. BMC Ophthalmol. 2019.03; 19 (1): 83. ( PubMed, DOI )

  • Arai A.. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development Frontiers Pediatrics. 2019.02;

  • Arai A.. Chronic active Epstein–Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements Immunological Medicine. 2019.01;

  • Yonese I, Takase H, Yoshimori M, Onozawa E, Tsuzura A, Miki T, Mochizuki M, Miura O, Arai A. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential. European journal of haematology. 2018.11; ( PubMed, DOI )

  • Onozawa E, Shibayama H, Takada H, Imadome KI, Aoki S, Yoshimori M, Shimizu N, Fujiwara S, Koyama T, Miura O, Arai A. STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target. Oncotarget. 2018.07; 9 (57): 31077-31089. ( PubMed, DOI )

display all >>

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  • Arai A, Yonese I, Sakashita C, Imadome KI, Kobayashi T, Sawada A, Itoh Y, Ohga S, Kimura H, Fujiwara S. Nationwide survey of chemotherapy for CAEBV in Japan. The 59th American Society of Hematology Annual Meeting & Exposition 2018.12.01 San Diego

  • Arai A, Yonese I, Takase H, Yoshimori M, Miki T, Mochizuki M, Miura O. CD79B Y196 mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential. The 80th Annual Meeting of the Japanese Society of Hematology 2018.10.12 Osaka

  • Yoshimori M , Shinki H, Imadome KI, Wu S, Tateishi M , Koyama T, Arai A. EBV-NK-cells induce procoagulant activity of monocytic and vascular endothelial cells causing DIC. The 80th Annual Meeting of the Japanese Society of Hematology 2018.10.12 Osaka

  • A Arai, C Sakashita, A Sawada, H Kimura. Nationwide survey of chemotherapy for CAEBV in Japan. The 77th Annual Meeting of the Japanese Cancer Association 2018.09.28

  • Arai A, Yonese I, Sakashita C, Imadome KI, Kobayashi T, Sawada A, Itoh Y, Ohga S, Kimura H, Fujiwara S. Nationwide survey of chemotherapy for CAEBV in Japan. 2018 International Conference on EBV and KSHV 2018.07.29 Madison, U.S.A

display all >>

To the head of this page.▲

Awards & Honors 【 display / non-display 】

  • Cerificate of Merit，Radiological Society of North Americ，2015.12

To the head of this page.▲
 

Campus class subject 【 display / non-display 】

  • Hematology，2010 - Now

To the head of this page.▲